Veterinary Vaccines Market worth $18.46 billion by 2031
The report "Veterinary Vaccines Market by Type (Porcine, Poultry, Bovine, Ruminant, Canine, Feline, Aquaculture), Technology (Live Attenuated, Inactivated, Toxoid, Recombinant), Route of Administration (Subcutaneous, Oral), End User - Global Forecast to 2031" is projected to reach USD 18.46 billion by 2031, up from an estimated USD 13.02 billion in 2026, at a CAGR of 7.2%.
Browse 450 market data Tables and 64 Figures spread through 406 Pages and in-depth TOC on "Veterinary Vaccines Market, by Type (Porcine, Poultry, Bovine, Ruminant, Canine, Feline, Aquaculture), Technology (Live Attenuated, Inactivated, Toxoid, Recombinant), Route of Administration (Subcutaneous, Oral), End User - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html
Globally, the growing awareness of animal health, increasing pet population and pet ownership, initiatives by various governments to improve animal health, and growing adoption of pet insurance policies are propelling the adoption of veterinary vaccines. A large number of pet owners, especially in major markets across North America and Europe, are purchasing pet insurance due to significant growth in pet care spending in recent years.
Moreover, the increasing focus on new and advanced product development and the growing adoption of veterinary vaccines in emerging economies are expected to support growth in the veterinary vaccines market during the forecast period. However, the high cost of vaccines is likely to hamper growth in the veterinary vaccines market.
The companion animal vaccines segment is expected to register the highest growth rate in the global veterinary vaccines market.
By type, the companion animal vaccines market is growing significantly, driven by rising pet ownership, heightened awareness of preventive healthcare, and the development of more effective and safer vaccines. As pets are increasingly viewed as family members, the demand for vaccinations to protect them from infectious diseases is rising. The growing recognition of zoonotic disease risks, government regulations, and the rise of pet insurance are further boosting vaccine demand. Additionally, emerging markets, particularly in the Asia Pacific, are contributing to this growth as disposable incomes rise and more pet owners seek veterinary care.
The veterinary hospitals segment is anticipated to grow at a significant rate in the veterinary vaccines market during the forecast period.
By application, the veterinary hospitals segment is growing rapidly as more pet owners seek professional care for their pets. With pets being treated like family, owners turn to veterinary hospitals for vaccinations and overall health care. These hospitals offer advanced vaccines and follow-up care, making them a go-to choice for ensuring pets stay healthy. Partnerships with pharmaceutical companies and the growing focus on preventive care are also helping drive this growth. As a result, veterinary hospitals are becoming an increasingly important part of the pet healthcare landscape.
The Asia Pacific market, by region, is expected to register the highest growth rate during the forecast period.
The veterinary vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is experiencing rapid growth in the veterinary vaccines market, driven by rising pet ownership, increasing awareness of pet health, and growing disposable incomes. As more people in countries such as China, India, and Southeast Asia adopt pets, there is a growing demand for veterinary care, including vaccinations. The expansion of veterinary hospitals, along with government initiatives to improve animal health and prevent zoonotic diseases, is further boosting vaccine adoption. This combination of factors makes the Asia Pacific one of the fastest-growing regions in the veterinary vaccines market.
As of 2025, the veterinary vaccines market was dominated by Zoetis (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco (US), Virbac (France), Ceva (France), Phibro Animal Health Corporation (US), Hester Biosciences Limited (India), Neogen Corporation (US), HIPRA (Spain), and Biogénesis Bagó (Argentina), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Veterinary Vaccines Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
